Table 3.
Clinical outcomes of COVID-19 patients.
Variable | N | Hospitalization time (days) | Percentiles | P |
---|---|---|---|---|
In total | 473 | 43.0 | – | |
Gender | 0.323 | |||
Male | 246 | 17.0 | (12.0, 21.0) | |
Female | 227 | 16.0 | (11.0, 20.0) | |
Age | 0.030 | |||
<42 | 223 | 16.0 | (11.0 ,20.0) | |
≥42 | 250 | 17.0 | (12.0, 21.0) | |
Patient type | 0.196 | |||
Local cases | 248 | 16.0 | (11.0, 20.0) | |
Imported cases | 225 | 17.0 | (12.0, 21.0) | |
Exposure history | 0.303 | |||
Living or traveling in Hubei | 194 | 17.0 | (12.0, 21.0) | |
Contact with confirmed patients | 244 | 16.0 | (11.0, 21.0) | |
Without contact history | 35 | 16.0 | (11.0, 20.0) | |
Symptom | 0.091 | |||
Fever | 255 | 17.0 | (13.0, 21.0) | |
Diarrhea | 13 | 14.0 | (10.75, 21.5) | |
Other symptom | 123 | 16.0 | (12.0, 20.0) | |
Without symptom | 82 | 14.0 | (10.75, 20.0) | |
Severity status | <0.001 | |||
General | 429 | 16.0 | (11.5, 20.0) | |
Severe | 26 | 20.5 | (14.75, 26.0) | |
Critical | 18 | 23.5 | (16.25, 32.25) |